SCHEMBL2156194

SCHEMBL2156194

O=C(O)N(CC1(CN(C(=O)O)c2cccc(C(F)(F)F)c2)CSc2c(Cl)cccc2C1=O)c1cccc(C(F)(F)F)c1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
RXFP1 Q9HBX9 1/20 0.36
RORC P51449 2/20 0.35
RORB Q92753 2/20 0.35
DGAT1 O75907 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
LTB4R2 Q9NPC1 2/20 0.34
TP53 P04637 1/20 0.34
HDAC1 Q13547 4/20 0.34
HDAC8 Q9BY41 4/20 0.34
HDAC6 Q9UBN7 4/20 0.34
MAPT P10636 1/20 0.34
HDAC5 Q9UQL6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2156975 0.91 MEN1 (0.37) MEN1KMT2ARXFP1DGAT1CYP1A2
SCHEMBL2156970 0.82 LMNA (0.37) MEN1KMT2ARXFP1RORCDGAT1
SCHEMBL2155535 0.77 MAPT (0.38) MEN1KMT2ARXFP1CYP1A2CYP3A4
SCHEMBL20357360 0.67 MEN1 (0.44) MEN1KMT2ACYP1A2CYP3A4CYP2C19
SCHEMBL4437768 0.65 MEN1 (0.54) MEN1KMT2ARXFP1CYP1A2CYP3A4
SCHEMBL2156009 0.65 L3MBTL1 (0.35)
SCHEMBL11503905 0.64 CES2 (0.45) MEN1KMT2ARXFP1CYP1A2CYP3A4
SCHEMBL1334800 0.62 HDAC1 (0.49) MEN1KMT2ARORCLTB4R2HDAC1
SCHEMBL1013242 0.62 CES2 (0.49) MEN1KMT2ATP53MAPT
SCHEMBL2155960 0.61 ALDH1A1 (0.35) MEN1KMT2ACYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973072-B2 Pain, eating disorders, neurodegenerative disorders, memory impairment; attention deficit syndrome, opioid tolerance, drug addiction; (4-oxothiochroman-3,3-diyl)bis(methylene)bis(3-(trifluoromethyl)benzoate for example GRUENENTHAL GMBH (DE) 2011-07-05 US claimed
US-7973072-B2 Pain, eating disorders, neurodegenerative disorders, memory impairment; attention deficit syndrome, opioid tolerance, drug addiction; (4-oxothiochroman-3,3-diyl)bis(methylene)bis(3-(trifluoromethyl)benzoate for example GRUENENTHAL GMBH (DE) 2011-07-05 US disclosed